While we focused on the JNK-MDR1 axis in mut-ER cells, studies showed that resistance to chemotherapy in breast cancer could evolve from a wide array of mechanisms [55], some of them are relevant to mut-ER cells. The gene discussed is ESR1; the disease is breast carcinoma.